Tech entrepreneur Bryan Johnson, known for his ambitious anti-aging efforts, has decided to stop taking rapamycin, an immunosuppressant drug he had used biweekly for nearly five years. Johnson’s decision came after growing concerns that the drug may have accelerated his aging process and caused adverse side effects, including skin infections and elevated blood sugar levels.
Rapamycin, sometimes used off-label for its potential anti-aging properties, has been controversial in the scientific community. Recent studies suggesting that the drug might increase biological aging further convinced Johnson to cease its use.
Johnson’s extensive anti-aging regimen, known as “Project Blueprint,” has included various experimental treatments. These range from plasma transfusions to a strict dietary regimen aimed at maximising his longevity. However, his approach has raised eyebrows among experts, many of whom caution against the unproven efficacy of such treatments and the risks they may entail.
Johnson’s decision to stop taking rapamycin has sparked further debate about the safety and effectiveness of anti-aging interventions, with some experts warning that the pursuit of longevity may not always yield the desired results.
Despite his concerns, Johnson remains committed to exploring new ways to extend his life, though his experience serves as a reminder that the pursuit of immortality may come with unintended consequences.
Who is Bryan Johnson?
Bryan Johnson is a tech entrepreneur and founder of Kernel, a neurotechnology company, and Braintree, a mobile payment system that was acquired by PayPal. Known for his ambitious approach to anti-aging, Johnson has invested millions in his quest to reverse the effects of aging through various experimental treatments, including a strict diet, plasma transfusions, and bi-weekly doses of rapamycin. His initiative, “Project Blueprint,” has gained attention for its focus on maximising longevity, though it has also drawn skepticism from experts due to the unproven nature and potential risks of these treatments. Despite this, Johnson remains dedicated to exploring cutting-edge methods to extend his life and improve his health.